These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 29057442)

  • 1. [Subcutaneous implantable cardioverter-defibrillator in prevention of sudden cardiac death in Poland - opinion paper endorsed by the Polish Cardiac Society Working Group on Heart Rhythm].
    Ptaszyński P; Grabowski M; Kowalski O; Kempa M; Mitkowski P; Przybylski A; Sterliński M
    Kardiol Pol; 2017; 75(10):1057-1060. PubMed ID: 29057442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subcutaneous implantable cardioverter defibrillator indication in prevention of sudden cardiac death in difficult clinical situations: A French expert position paper.
    Probst V; Boveda S; Sadoul N; Marquié C; Chauvin M; Mondoly P; Gras D; Jacon P; Defaye P; Leclercq C; Anselme F
    Arch Cardiovasc Dis; 2020 May; 113(5):359-366. PubMed ID: 32334981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial experience with the subcutaneous implantable cardioverter-defibrillator with the real costs of hospitalization analysis in a single Polish center.
    Grabowski M; Gawałko M; Michalak M; Cacko A; Kowara M; Kołodzińska A; Januszkiewicz Ł; Balsam P; Vitali Serdoz L; Winter J; Opolski G
    Cardiol J; 2019; 26(4):360-367. PubMed ID: 29611175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polish single-centre follow-up of subcutaneous implantable cardioverter-defibrillator (S-ICD) systems implanted for the prevention of sudden cardiac death.
    Kempa M; Budrejko S; Sławiński G; Królak T; Lewicka E; Raczak G
    Kardiol Pol; 2018; 76(2):452-458. PubMed ID: 29350391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Italian subcutaneous implantable cardioverter-defibrillator survey: S-ICD, why not?
    Botto GL; Forleo GB; Capucci A; Solimene F; Vado A; Bertero G; Palmisano P; Pisanò E; Rapacciuolo A; Infusino T; Vicentini A; Viscusi M; Ferrari P; Talarico A; Russo G; Boriani G; Padeletti L; Lovecchio M; Valsecchi S; D'Onofrio A;
    Europace; 2017 Nov; 19(11):1826-1832. PubMed ID: 28011803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The subcutaneous cardioverter-defibrillator: When less is more].
    Kuschyk J; Rudic B; Akin I; Borggrefe M; Röger S
    Herzschrittmacherther Elektrophysiol; 2015 Jun; 26(2):123-8. PubMed ID: 26058997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canadian Cardiovascular Society/Canadian Heart Rhythm Society 2016 Implantable Cardioverter-Defibrillator Guidelines.
    Bennett M; Parkash R; Nery P; Sénéchal M; Mondesert B; Birnie D; Sterns LD; Rinne C; Exner D; Philippon F; Campbell D; Cox J; Dorian P; Essebag V; Krahn A; Manlucu J; Molin F; Slawnych M; Talajic M
    Can J Cardiol; 2017 Feb; 33(2):174-188. PubMed ID: 28034580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The subcutaneous ICD as an alternative to the conventional ICD system: Initial experience in Greece and a review of the literature.
    Sideris S; Archontakis S; Gatzoulis KA; Anastasakis A; Sotiropoulos I; Arsenos P; Kasiakogias A; Terentes D; Trachanas K; Paschalidis E; Tousoulis D; Kallikazaros I
    Hellenic J Cardiol; 2017; 58(1):4-16. PubMed ID: 28163146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcutaneous implantable cardioverter defibrillator: Can it overtake its transvenous counterpart.
    Savarimuthu S; Roy S; Obeidat M; Harky A
    Pacing Clin Electrophysiol; 2021 Aug; 44(8):1413-1420. PubMed ID: 33878197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Experience With the Subcutaneous Implantable Cardioverter-Defibrillator in Adults With Congenital Heart Disease.
    Moore JP; Mondésert B; Lloyd MS; Cook SC; Zaidi AN; Pass RH; John AS; Fish FA; Shannon KM; Aboulhosn JA; Khairy P;
    Circ Arrhythm Electrophysiol; 2016 Sep; 9(9):. PubMed ID: 27635073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sudden cardiac death in the youth. Is the new subcutaneous implantable cardioverter defibrillator S-ICD an alternative solution?].
    Roche NC; Stefuriac M; Dumitrescu N; Charbonnel A; Godreuil C; Bonnevie L
    Ann Cardiol Angeiol (Paris); 2015 Feb; 64(1):27-31. PubMed ID: 25281995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of the subcutaneous implantable cardioverter-defibrillator for reducing sudden cardiac death.
    Sanghera R; Sanders R; Husby M; Bentsen JG
    Ann N Y Acad Sci; 2014 Nov; 1329():1-17. PubMed ID: 25308791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The need for a subsequent transvenous system in patients implanted with subcutaneous implantable cardioverter-defibrillator.
    Gasperetti A; Schiavone M; Vogler J; Laredo M; Fastenrath F; Palmisano P; Ziacchi M; Angeletti A; Mitacchione G; Kaiser L; Compagnucci P; Breitenstein A; Arosio R; Vitali F; De Bonis S; Picarelli F; Casella M; Santini L; Pignalberi C; Lavalle C; Pisanò E; Ricciardi D; Calò L; Curnis A; Bertini M; Gulletta S; Dello Russo A; Badenco N; Tondo C; Kuschyk J; Tilz R; Forleo GB; Biffi M
    Heart Rhythm; 2022 Dec; 19(12):1958-1964. PubMed ID: 35781042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific indications and clinical outcome in patients with subcutaneous implantable cardioverter-defibrillator (ICD) - A nationwide multicentre registry.
    Sponder M; Khazen C; Dichtl W; Fiedler L; Mörtl D; Teubl A; Steinwender C; Martinek M; Nürnberg M; Dalos D; Kastner J; Schukro C
    Eur J Intern Med; 2018 Feb; 48():64-68. PubMed ID: 28978409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sudden cardiac death: New approaches for implantable cardioverter-defibrillators (ICDs).
    Cappato R; Ali H
    Int J Cardiol; 2017 Jun; 237():38-41. PubMed ID: 28377192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous versus transvenous implantable cardioverter defibrillators in children and young adults: A meta-analysis.
    Vetta G; Parlavecchio A; Magnocavallo M; Valente D; Caminiti R; Polselli M; Vetta F; Cirone D; Cauti FM; Crea P; Rossi P; Chierchia GB; Bianchi S; de Asmundis C; Natale A; Della Rocca DG
    Pacing Clin Electrophysiol; 2022 Dec; 45(12):1409-1414. PubMed ID: 36214206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of subcutaneous implantable cardioverter-defibrillators and determinants of inappropriate shock delivery.
    Mesquita J; Cavaco D; Ferreira A; Lopes N; Santos PG; Carvalho MS; Haas A; Costa F; Carmo P; Morgado F; Adragão P; Mendes M
    Int J Cardiol; 2017 Apr; 232():176-180. PubMed ID: 28082086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcutaneous implantable cardioverter-defibrillator in primary and secondary prevention of sudden cardiac death: A meta-analysis.
    León Salas B; Trujillo-Martín MM; García García J; Ramallo Fariña Y; García Quintana A; Quirós López R; Serrano-Aguilar P
    Pacing Clin Electrophysiol; 2019 Sep; 42(9):1253-1268. PubMed ID: 31396970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of sudden cardiac death: the role of the implantable cardioverter-defibrillator.
    Sinha SK; Mehta D; Gomes JA
    Mt Sinai J Med; 2005 Jan; 72(1):1-9. PubMed ID: 15682255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experts of the Heart Rhythm Section of the Polish Cardiac Society: opinion on the use of wearable cardioverter-defibrillators in Poland.
    Sterliński M; Oręziak A; Przybylski A; Średniawa B
    Kardiol Pol; 2019; 77(2):238-243. PubMed ID: 30816992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.